Skip to content

Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes

Real-Time Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03844646
Enrollment
12
Registered
2019-02-18
Start date
2019-08-01
Completion date
2021-12-31
Last updated
2023-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PreDiabetes, Weight Loss

Brief summary

The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.

Detailed description

Continuous glucose monitoring (CGM) has revolutionized the treatment of patients on intensive insulin therapy and its utility can also be harnessed to help individuals with prediabetes make healthful lifestyle changes. Successful weight loss requires adherence to lower calories, regular exercise, and self-monitoring. This proposal will test the hypothesis that intermittent CGM will facilitate all of these components for successful weight loss by functioning as a continuous self-monitor and guiding healthful food choices and physical activity.

Interventions

DEVICECGM

Intermittent use of a continuous glucose monitor (CGM)

OTHERDietitian

Monthly meetings with a dietitian

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Overweight/obese (BMI 25-40 kg/m2) * Prediabetes (fasting glucose 100-125 mg/dL and/or HbA1c 5.7-6.4%)

Exclusion criteria

* On glucose-lowering medications (e.g., metformin) * On weight-loss medications

Design outcomes

Primary

MeasureTime frameDescription
Amount of Weight Lost (kg)Baseline to end of study (3 months)Weight lost during the study

Secondary

MeasureTime frame
Number of Participants Reporting at Least 5 Days of Moderate Physical Activity of 30 Minutes or MoreBaseline to end of study (3 months)

Countries

United States

Participant flow

Participants by arm

ArmCount
CGM Plus Dietitian
Intermittent use of a continuous glucose monitor (CGM) plus monthly support meetings with a dietitian.
8
Dietitian Only
Monthly support meetings with a dietitian.
4
Total12

Baseline characteristics

CharacteristicTotalDietitian OnlyCGM Plus Dietitian
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants1 Participants2 Participants
Age, Categorical
Between 18 and 65 years
9 Participants3 Participants6 Participants
Race/Ethnicity, Customized
Asian
5 Participants2 Participants3 Participants
Race/Ethnicity, Customized
Hispanic
2 Participants0 Participants2 Participants
Race/Ethnicity, Customized
NonHispanic White
5 Participants2 Participants3 Participants
Region of Enrollment
United States
12 Participants4 Participants8 Participants
Sex: Female, Male
Female
8 Participants2 Participants6 Participants
Sex: Female, Male
Male
4 Participants2 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 4
other
Total, other adverse events
0 / 80 / 4
serious
Total, serious adverse events
0 / 80 / 4

Outcome results

Primary

Amount of Weight Lost (kg)

Weight lost during the study

Time frame: Baseline to end of study (3 months)

ArmMeasureGroupValue (MEAN)Dispersion
CGM Plus DietitianAmount of Weight Lost (kg)Baseline77.4 kgStandard Deviation 8.4
CGM Plus DietitianAmount of Weight Lost (kg)Change at month 3-2.9 kgStandard Deviation 4
Dietitian OnlyAmount of Weight Lost (kg)Baseline74.9 kgStandard Deviation 7.5
Dietitian OnlyAmount of Weight Lost (kg)Change at month 3-3.1 kgStandard Deviation 0.6
Secondary

Number of Participants Reporting at Least 5 Days of Moderate Physical Activity of 30 Minutes or More

Time frame: Baseline to end of study (3 months)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
CGM Plus DietitianNumber of Participants Reporting at Least 5 Days of Moderate Physical Activity of 30 Minutes or More4 Participants
Dietitian OnlyNumber of Participants Reporting at Least 5 Days of Moderate Physical Activity of 30 Minutes or More2 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026